oxprenolol has been researched along with Cachexia in 1 studies
Oxprenolol: A beta-adrenergic antagonist used in the treatment of hypertension, angina pectoris, arrhythmias, and anxiety.
Cachexia: General ill health, malnutrition, and weight loss, usually associated with chronic disease.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In the Yoshida AH130 hepatoma rat cancer cachexia model and compared with placebo, 50 mg/kg/d S-oxprenolol (HR: 0." | 8.31 | The atypical β-blocker S-oxprenolol reduces cachexia and improves survival in a rat cancer cachexia model. ( Álvarez Ladrón, N; Alves de Lima Junior, E; Anker, MS; Anker, SD; Argiles, JM; Busquets, S; Coats, AJS; Jové, Q; López-Soriano, FJ; Millman, O; Oosterlee, A; Palus, S; Springer, J; Szymczyk, A; von Haehling, S; Yuan, L, 2023) |
| "In the Yoshida AH130 hepatoma rat cancer cachexia model and compared with placebo, 50 mg/kg/d S-oxprenolol (HR: 0." | 4.31 | The atypical β-blocker S-oxprenolol reduces cachexia and improves survival in a rat cancer cachexia model. ( Álvarez Ladrón, N; Alves de Lima Junior, E; Anker, MS; Anker, SD; Argiles, JM; Busquets, S; Coats, AJS; Jové, Q; López-Soriano, FJ; Millman, O; Oosterlee, A; Palus, S; Springer, J; Szymczyk, A; von Haehling, S; Yuan, L, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yuan, L | 1 |
| Springer, J | 1 |
| Palus, S | 1 |
| Busquets, S | 1 |
| Jové, Q | 1 |
| Alves de Lima Junior, E | 1 |
| Anker, MS | 1 |
| von Haehling, S | 1 |
| Álvarez Ladrón, N | 1 |
| Millman, O | 1 |
| Oosterlee, A | 1 |
| Szymczyk, A | 1 |
| López-Soriano, FJ | 1 |
| Anker, SD | 1 |
| Coats, AJS | 1 |
| Argiles, JM | 1 |
1 other study available for oxprenolol and Cachexia
| Article | Year |
|---|---|
The atypical β-blocker S-oxprenolol reduces cachexia and improves survival in a rat cancer cachexia model.
Topics: Adrenergic beta-Antagonists; Animals; Cachexia; Humans; Liver Neoplasms; Mice; Oxprenolol; Pindolol; | 2023 |